Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammation.

Egli-Spichtig D, Imenez Silva PH, Glaudemans B, Gehring N, Bettoni C, Zhang MYH, Pastor-Arroyo EM, Schönenberger D, Rajski M, Hoogewijs D, Knauf F, Misselwitz B, Frey-Wagner I, Rogler G, Ackermann D, Ponte B, Pruijm M, Leichtle A, Fiedler GM, Bochud M, Ballotta V, Hofmann S, Perwad F, Föller M, Lang F, Wenger RH, Frew I, Wagner CA.

Kidney Int. 2019 May 14. pii: S0085-2538(19)30465-X. doi: 10.1016/j.kint.2019.04.009. [Epub ahead of print]

PMID:
31301888
2.

A preliminary survey of practice patterns across several European kidney stone centers and a call for action in developing shared practice.

Ferraro PM, Arrabal-Polo MÁ, Capasso G, Croppi E, Cupisti A, Ernandez T, Fuster DG, Galan JA, Grases F, Hoorn EJ, Knauf F, Letavernier E, Mohebbi N, Moochhala S, Petkova K, Pozdzik A, Sayer J, Seitz C, Strazzullo P, Trinchieri A, Vezzoli G, Vitale C, Vogt L, Unwin RJ, Bonny O, Gambaro G.

Urolithiasis. 2019 Jun;47(3):219-224. doi: 10.1007/s00240-019-01119-z. Epub 2019 Mar 8.

PMID:
30848320
3.

Challenges to hypertension and diabetes management in rural Uganda: a qualitative study with patients, village health team members, and health care professionals.

Chang H, Hawley NL, Kalyesubula R, Siddharthan T, Checkley W, Knauf F, Rabin TL.

Int J Equity Health. 2019 Feb 28;18(1):38. doi: 10.1186/s12939-019-0934-1.

4.

Immunity, microbiota and kidney disease.

Knauf F, Brewer JR, Flavell RA.

Nat Rev Nephrol. 2019 May;15(5):263-274. doi: 10.1038/s41581-019-0118-7. Review.

PMID:
30796361
5.

Characterization of renal NaCl and oxalate transport in Slc26a6-/- mice.

Knauf F, Velazquez H, Pfann V, Jiang Z, Aronson PS.

Am J Physiol Renal Physiol. 2019 Jan 1;316(1):F128-F133. doi: 10.1152/ajprenal.00309.2018. Epub 2018 Nov 14.

PMID:
30427220
6.

A Successful Approach to Kidney Transplantation in Patients With Enteric (Secondary) Hyperoxaluria.

Roodnat JI, de Mik-van Egmond AME, Visser WJ, Berger SP, van der Meijden WAG, Knauf F, van Agteren M, Betjes MGH, Hoorn EJ.

Transplant Direct. 2017 Nov 8;3(12):e331. doi: 10.1097/TXD.0000000000000748. eCollection 2017 Dec.

7.

Impact of Regular or Extended Hemodialysis and Hemodialfiltration on Plasma Oxalate Concentrations in Patients With End-Stage Renal Disease.

Ermer T, Kopp C, Asplin JR, Granja I, Perazella MA, Reichel M, Nolin TD, Eckardt KU, Aronson PS, Finkelstein FO, Knauf F.

Kidney Int Rep. 2017 Jun 8;2(6):1050-1058. doi: 10.1016/j.ekir.2017.06.002. eCollection 2017 Nov.

8.

Implementation of Patient-Centered Education for Chronic-Disease Management in Uganda: An Effectiveness Study.

Siddharthan T, Rabin T, Canavan ME, Nassali F, Kirchhoff P, Kalyesubula R, Coca S, Rastegar A, Knauf F.

PLoS One. 2016 Nov 16;11(11):e0166411. doi: 10.1371/journal.pone.0166411. eCollection 2016.

9.

Update on Nephrolithiasis: Core Curriculum 2016.

Pfau A, Knauf F.

Am J Kidney Dis. 2016 Dec;68(6):973-985. doi: 10.1053/j.ajkd.2016.05.016. Epub 2016 Aug 3. No abstract available.

PMID:
27497526
10.

Loss of Cystic Fibrosis Transmembrane Regulator Impairs Intestinal Oxalate Secretion.

Knauf F, Thomson RB, Heneghan JF, Jiang Z, Adebamiro A, Thomson CL, Barone C, Asplin JR, Egan ME, Alper SL, Aronson PS.

J Am Soc Nephrol. 2017 Jan;28(1):242-249. doi: 10.1681/ASN.2016030279. Epub 2016 Jun 16.

11.

Oxalate, inflammasome, and progression of kidney disease.

Ermer T, Eckardt KU, Aronson PS, Knauf F.

Curr Opin Nephrol Hypertens. 2016 Jul;25(4):363-71. doi: 10.1097/MNH.0000000000000229. Review.

12.

Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL/6 mice.

Mulay SR, Eberhard JN, Pfann V, Marschner JA, Darisipudi MN, Daniel C, Romoli S, Desai J, Grigorescu M, Kumar SV, Rathkolb B, Wolf E, Hrabě de Angelis M, Bäuerle T, Dietel B, Wagner CA, Amann K, Eckardt KU, Aronson PS, Anders HJ, Knauf F.

Am J Physiol Renal Physiol. 2016 Apr 15;310(8):F785-F795. doi: 10.1152/ajprenal.00488.2015. Epub 2016 Jan 13.

13.

Prevention of diet-induced hepatic steatosis and hepatic insulin resistance by second generation antisense oligonucleotides targeted to the longevity gene mIndy (Slc13a5).

Pesta DH, Perry RJ, Guebre-Egziabher F, Zhang D, Jurczak M, Fischer-Rosinsky A, Daniels MA, Willmes DM, Bhanot S, Bornstein SR, Knauf F, Samuel VT, Shulman GI, Birkenfeld AL.

Aging (Albany NY). 2015 Dec;7(12):1086-93.

14.

[Diagnosis and treatment of nephrolithiasis. What is established?].

Pfau A, Eckardt KU, Knauf F.

Internist (Berl). 2015 Dec;56(12):1361-8. doi: 10.1007/s00108-015-3758-0. Review. German.

PMID:
26530696
15.

An update on the role of the inflammasomes in the pathogenesis of kidney diseases.

Darisipudi MN, Knauf F.

Pediatr Nephrol. 2016 Apr;31(4):535-44. doi: 10.1007/s00467-015-3153-z. Epub 2015 Jul 16. Review.

PMID:
26178650
16.

Targeted resequencing and systematic in vivo functional testing identifies rare variants in MEIS1 as significant contributors to restless legs syndrome.

Schulte EC, Kousi M, Tan PL, Tilch E, Knauf F, Lichtner P, Trenkwalder C, Högl B, Frauscher B, Berger K, Fietze I, Hornyak M, Oertel WH, Bachmann CG, Zimprich A, Peters A, Gieger C, Meitinger T, Müller-Myhsok B, Katsanis N, Winkelmann J.

Am J Hum Genet. 2014 Jul 3;95(1):85-95. doi: 10.1016/j.ajhg.2014.06.005.

17.

Restless legs syndrome-associated intronic common variant in Meis1 alters enhancer function in the developing telencephalon.

Spieler D, Kaffe M, Knauf F, Bessa J, Tena JJ, Giesert F, Schormair B, Tilch E, Lee H, Horsch M, Czamara D, Karbalai N, von Toerne C, Waldenberger M, Gieger C, Lichtner P, Claussnitzer M, Naumann R, Müller-Myhsok B, Torres M, Garrett L, Rozman J, Klingenspor M, Gailus-Durner V, Fuchs H, Hrabě de Angelis M, Beckers J, Hölter SM, Meitinger T, Hauck SM, Laumen H, Wurst W, Casares F, Gómez-Skarmeta JL, Winkelmann J.

Genome Res. 2014 Apr;24(4):592-603. doi: 10.1101/gr.166751.113. Epub 2014 Mar 18.

18.

Dabigatran and kidney disease: a bad combination.

Knauf F, Chaknos CM, Berns JS, Perazella MA.

Clin J Am Soc Nephrol. 2013 Sep;8(9):1591-7. doi: 10.2215/CJN.01260213. Epub 2013 Jul 18. Review.

19.

NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy.

Knauf F, Asplin JR, Granja I, Schmidt IM, Moeckel GW, David RJ, Flavell RA, Aronson PS.

Kidney Int. 2013 Nov;84(5):895-901. doi: 10.1038/ki.2013.207. Epub 2013 Jun 5.

20.

The role of SCARB2 as susceptibility factor in Parkinson's disease.

Hopfner F, Schulte EC, Mollenhauer B, Bereznai B, Knauf F, Lichtner P, Zimprich A, Haubenberger D, Pirker W, Brücke T, Peters A, Gieger C, Kuhlenbäumer G, Trenkwalder C, Winkelmann J.

Mov Disord. 2013 Apr;28(4):538-40. doi: 10.1002/mds.25349. Epub 2013 Feb 13.

PMID:
23408458
21.

Sat1 is dispensable for active oxalate secretion in mouse duodenum.

Ko N, Knauf F, Jiang Z, Markovich D, Aronson PS.

Am J Physiol Cell Physiol. 2012 Jul 1;303(1):C52-7. doi: 10.1152/ajpcell.00385.2011. Epub 2012 Apr 18.

22.

Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features.

Hopfner F, Schormair B, Knauf F, Berthele A, Tölle TR, Baron R, Maier C, Treede RD, Binder A, Sommer C, Maihöfner C, Kunz W, Zimprich F, Heemann U, Pfeufer A, Näbauer M, Kääb S, Nowak B, Gieger C, Lichtner P, Trenkwalder C, Oexle K, Winkelmann J.

BMC Neurol. 2011 Oct 27;11:134. doi: 10.1186/1471-2377-11-134.

23.

Net intestinal transport of oxalate reflects passive absorption and SLC26A6-mediated secretion.

Knauf F, Ko N, Jiang Z, Robertson WG, Van Itallie CM, Anderson JM, Aronson PS.

J Am Soc Nephrol. 2011 Dec;22(12):2247-55. doi: 10.1681/ASN.2011040433. Epub 2011 Oct 21.

24.

Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice.

Birkenfeld AL, Lee HY, Guebre-Egziabher F, Alves TC, Jurczak MJ, Jornayvaz FR, Zhang D, Hsiao JJ, Martin-Montalvo A, Fischer-Rosinsky A, Spranger J, Pfeiffer AF, Jordan J, Fromm MF, König J, Lieske S, Carmean CM, Frederick DW, Weismann D, Knauf F, Irusta PM, De Cabo R, Helfand SL, Samuel VT, Shulman GI.

Cell Metab. 2011 Aug 3;14(2):184-95. doi: 10.1016/j.cmet.2011.06.009. Erratum in: Cell Metab. 2011 Oct 5;14(4):567.

25.

Drosophila: a fruitful model for calcium oxalate nephrolithiasis?

Knauf F, Preisig PA.

Kidney Int. 2011 Aug;80(4):327-9. doi: 10.1038/ki.2011.166.

26.

Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1.

Winkelmann J, Czamara D, Schormair B, Knauf F, Schulte EC, Trenkwalder C, Dauvilliers Y, Polo O, Högl B, Berger K, Fuhs A, Gross N, Stiasny-Kolster K, Oertel W, Bachmann CG, Paulus W, Xiong L, Montplaisir J, Rouleau GA, Fietze I, Vávrová J, Kemlink D, Sonka K, Nevsimalova S, Lin SC, Wszolek Z, Vilariño-Güell C, Farrer MJ, Gschliesser V, Frauscher B, Falkenstetter T, Poewe W, Allen RP, Earley CJ, Ondo WG, Le WD, Spieler D, Kaffe M, Zimprich A, Kettunen J, Perola M, Silander K, Cournu-Rebeix I, Francavilla M, Fontenille C, Fontaine B, Vodicka P, Prokisch H, Lichtner P, Peppard P, Faraco J, Mignot E, Gieger C, Illig T, Wichmann HE, Müller-Myhsok B, Meitinger T.

PLoS Genet. 2011 Jul;7(7):e1002171. doi: 10.1371/journal.pgen.1002171. Epub 2011 Jul 14. Erratum in: PLoS Genet. 2011 Aug;7(8). doi: 10.1371/annotation/393ad2d3-df4f-4770-87bc-00bfabf79362.

27.

Variant screening of the coding regions of MEIS1 in patients with restless legs syndrome.

Schulte EC, Knauf F, Kemlink D, Schormair B, Lichtner P, Gieger C, Meitinger T, Winkelmann J.

Neurology. 2011 Mar 22;76(12):1106-8. doi: 10.1212/WNL.0b013e318211c366. No abstract available.

PMID:
21422461
28.

ESRD as a window into America's cost crisis in health care.

Knauf F, Aronson PS.

J Am Soc Nephrol. 2009 Oct;20(10):2093-7. doi: 10.1681/ASN.2009070715. Epub 2009 Sep 3. No abstract available.

29.

A case of extreme hemodynamic lability and hypocalcemia.

Knauf F, Desir GV, Perazella MA.

Am J Med Sci. 2009 Sep;338(3):241-4. doi: 10.1097/MAJ.0b013e3181a66af1.

PMID:
19590425
30.

The life-extending gene Indy encodes an exchanger for Krebs-cycle intermediates.

Knauf F, Mohebbi N, Teichert C, Herold D, Rogina B, Helfand S, Gollasch M, Luft FC, Aronson PS.

Biochem J. 2006 Jul 1;397(1):25-9.

31.

Role of dipeptidyl peptidase IV in regulating activity of Na+/H+ exchanger isoform NHE3 in proximal tubule cells.

Girardi AC, Knauf F, Demuth HU, Aronson PS.

Am J Physiol Cell Physiol. 2004 Nov;287(5):C1238-45. Epub 2004 Jun 22.

32.

Functional characterization and immunolocalization of the transporter encoded by the life-extending gene Indy.

Knauf F, Rogina B, Jiang Z, Aronson PS, Helfand SL.

Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14315-9. Epub 2002 Oct 21.

33.

Identification of a chloride-formate exchanger expressed on the brush border membrane of renal proximal tubule cells.

Knauf F, Yang CL, Thomson RB, Mentone SA, Giebisch G, Aronson PS.

Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9425-30. Epub 2001 Jul 17.

Supplemental Content

Support Center